Processa Pharmaceuticals, Inc. (PCSA)
Total Valuation
PCSA has a market cap or net worth of $3.88 million. The enterprise value is -$2.81 million.
Market Cap | 3.88M |
Enterprise Value | -2.81M |
Important Dates
The next estimated earnings date is Monday, May 13, 2024, after market close.
Earnings Date | May 13, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
PCSA has 1.71 million shares outstanding. The number of shares has increased by 66.68% in one year.
Shares Outstanding | 1.71M |
Shares Change (YoY) | +66.68% |
Shares Change (QoQ) | +0.25% |
Owned by Insiders (%) | 15.06% |
Owned by Institutions (%) | 2.59% |
Float | 969,865 |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.54 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.57, with a Debt / Equity ratio of 0.02.
Current Ratio | 9.57 |
Quick Ratio | n/a |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -256.10% and return on invested capital (ROIC) is -297.98%.
Return on Equity (ROE) | -256.10% |
Return on Assets (ROA) | -221.60% |
Return on Capital (ROIC) | -297.98% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.45M |
Employee Count | 15 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -76.35% in the last 52 weeks. The beta is 0.52, so PCSA's price volatility has been lower than the market average.
Beta (1Y) | 0.52 |
52-Week Price Change | -76.35% |
50-Day Moving Average | 2.49 |
200-Day Moving Average | 6.88 |
Relative Strength Index (RSI) | 47.07 |
Average Volume (30 Days) | 1,583,130 |
Short Selling Information
The latest short interest is 40,248, so 2.36% of the outstanding shares have been sold short.
Short Interest | 40,248 |
Short Previous Month | 67,298 |
Short % of Shares Out | 2.36% |
Short % of Float | 4.15% |
Short Ratio (days to cover) | 0.43 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -21.87M |
Pretax Income | -21.73M |
Net Income | -21.73M |
EBITDA | -21.45M |
EBIT | -21.73M |
Earnings Per Share (EPS) | -$23.20 |
Balance Sheet
The company has $6.86 million in cash and $171,521 in debt, giving a net cash position of $6.69 million or $3.92 per share.
Cash & Cash Equivalents | 6.86M |
Total Debt | 171,521 |
Net Cash | 6.69M |
Net Cash Per Share | $3.92 |
Equity / Book Value | 7.17M |
Book Value Per Share | 4.20 |
Working Capital | 7.08M |
Cash Flow
Operating Cash Flow | -8.44M |
Capital Expenditures | n/a |
Free Cash Flow | -8.44M |
FCF Per Share | -$6.25 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
PCSA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -66.68% |
Shareholder Yield | -66.68% |
Earnings Yield | -560.54% |
FCF Yield | -217.65% |
Analyst Forecast
The average price target for PCSA is $48.00, which is 1,929.60% higher than the current price. The consensus rating is "Buy".
Price Target | $48.00 |
Price Target Difference | 1,929.60% |
Analyst Consensus | Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 22, 2024. It was a reverse split with a ratio of 1:20.
Last Split Date | Jan 22, 2024 |
Split Type | Reverse |
Split Ratio | 1:20 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 3 |